Lack of association between chronic Chlamydophila pneumoniae infection and lung cancer among nonsmoking Chinese women in Singapore [2]

International Journal of Cancer

Volumn 114, Issue 3, 2005, Pages 502-504

  Koh, Woon Puay ^a   Chow, Vincent T K ^a   Phoon, Meng Chee ^a   Ramachandran, Narayana ^a   Seow, Adeline ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; BACTERIAL INFECTION; BLOOD SAMPLING; CANCER RISK; CHLAMYDOPHILA PNEUMONIAE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOFLUORESCENCE; INTERVIEW; LETTER; LUNG CANCER; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SINGAPORE; SMOKING; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHINA; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; FEMALE; HUMANS; IMMUNOGLOBULIN G; LUNG NEOPLASMS; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SINGAPORE; SMOKING;

EID: 14044277548     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20745     Document Type: Letter

References (23)

1. Laurila AL, Anttila T, Laara E, Bloigu A, Virtamo J, Albanes D, Leinonen M, Saikku P. Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int J Cancer 1997;74:31-4.
2. Anttila T, Koskela P, Leinonen M, Laukkanen P, Hakulinen T, Lehtinen M, Pukkala E, Paavonen J, Saikku P. Chlamydia pneumoniae infection and the risk of female early-onset lung cancer. Int J Cancer 2003;107:681-2.
3. Kocazeybek B. Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case-control study. J Med Microbiol 2003;52:721-6.
4. Jackson LA, Wang SP, Nazar-Stewart V, Grayston JT, Vaughan TL. Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer. Cancer Epidemiol Biomarkers Prev 2000;9:1263-6.
5. Koyi H, Branden E, Gnarpe J, Gnarpe H, Steen B. An association between chronic infection with Chlamydia pneumoniae and lung cancer: a prospective 2-year study. APMIS 2001;109:572-80.
6. von Hertzen L, Kaprio J, Koskenvuo M, Isoaho R, Saikku P. Humoral immune response to Chlamydia pneumoniae in twin discordant for smoking. J Intern Med 1998;244:227-34.
7. Karvonen M, Tuomilehto J, Pitkaniemi J, Naukkarinen A, Saikku P. Importance of smoking for Chlamydia pneumoniae seropositivity. Int J Epidemiol 1994;23:1315-21.
8. Gnarpe J, Gnarpe H, Gause-Nilsson I, Lundorg P, Steen B. Seroprevalence of antibodies to Chlamydia pneumoniae in elderly people: a two-decade longitudinal and cohort difference study. Scand J Infect Dis 2000;32:177-9.
9. von Hertzen L, Surcel HM, Kaprio J, Koskenvuo M, Bloigu A, Leinonen M, Saikku P. Immune responses to Chlamydia pneumoniae in twins in relation to gender and smoking. J Med Microbiol 1998;47:441-6.
10. Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994;305:253-64.
11. Redecke V, Dalhoff K, Bohnet S, Braun J, Maass M. Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response. Am J Respir Cell Mol Biol 1998;19:721-7.
12. Huittinen T, Leinonen M, Tenkanen L, Virkkunen H, Manttari M, Palosuo T, Manninen V, Saikku P. Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk. Circulation 2003;107:2566-70.
13. Thom DH, Grayston JT, Siscovick DS, Wang SP, Weiss NS, Daling JR. Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. Jama 1992;268:68-72.
14. Koh WP, Taylor MB, Hughes K, Chew SK, Fong CW, Phoon MC, Kang KL, Chow VT. Seroprevalence of IgG antibodies against Chlamydia pneumoniae in Chinese, Malays and Asian Indians in Singapore. Int J Epidemiol 2002;31:1001-7.
15. Ni AP, Lin GY, Yang L, He HY, Huang CW, Liu ZJ, Wang RS, Zhang JS, Yu JY, Li N, Wang JB, Yang HY. A seroepidemiologic study of Chlamydia pneumoniae, Chlamydia trachomatis and Chlamydia psittaci in different populations on the mainland of China. Scand J Infect Dis 1996;28:553-7.
16. Kanamoto Y, Ouchi K, Mizui M, Ushio M, Usui T. Prevalence of antibody to Chlamydia pneumoniae TWAR in Japan. J Clin Microbiol 1991;29:816-8.
17. Choi TY, Kim DA, Kim SK, Kang JO, Park SS, Jung SR. Prevalence of specific antibodies to Chlamydia pneumoniae in Korea. J Clin Microbiol 1998;36:3426-8.
18. Wang JH, Liu YC, Cheng DL, Yeng MY, Chen YS, Chen BC. Seroprevalence of Chlamydia pneumoniae in Taiwan. Scand J Infect Dis 1993;25:565-8.
19. Leowattana W, Mahanonda N, Bhuripanyo K, Pokum S. Seroprevalence of Chlamydia pneumoniae infection in Thailand. J Med Assoc Thai 2000;83:S1-5.
20. Epidemiology and Disease Control Department, Singapore National Health Survey 1998, Ministry of Health, Singapore, 1999.
21. Seow A, Poh WT, Teh M, Eng P, Wang YT, Tan WC, Yu MC, Lee HP. Fumes from meat cooking and lung cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev 2000;9:1215-21.
22. el-Rabadi K, Gottsauner-Wolf M, Christ G, Maurer G, Huber K. Chlamydia antibody titers in patients with coronary disease: relations to age and clinical stage. Wien Klin Wochenschr 2001;113:727-30.
23. Gattone M, Iacoviello L, Colombo M, Castelnuovo AD, Soffiantino F, Gramoni A, Picco D, Benedetta M, Giannuzzi P. Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age. Am Heart J 2001;142:633-40.